Company Name Recardio
Mailing Address 1 Market Street Spear Tower 36th Floor San Francisco, CA 94105 USA
Company Description RECARDIO (REgenerative CARDIOvascular Therapy) is an Austrian based life science company founded in 2011. It is focusing on drug based regenerative therapeutic modalities for the treatment of cardiovascular diseases.
Proceeds Purposes The proceeds will be used to advance a Phase 2 clinical trial for Recardio’s lead therapeutic candidate, Dutogliptin, which is being developed for the treatment of acute myocardial infarction (AMI), commonly known as heart attack.